Sunil Paliwal

This inventor holds 28 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Opko Health, Inc., Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sunil Paliwal. Retrieved from https://idiyas.com/inventor/sunil-paliwal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 14)

% Patents Active = 78.6

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 21)

Average Co-Inventor Count = 7.8

ph-index = 9

Forward Citations = 199(Granted Patents)

Location History:

Scotch Plains, NJ (US) (2002 - 2006)
Kenilworth, NJ (US) (2014)
Monroe Township, NJ (US) (2008 - 2024)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

4. 2 out of 30

Recurium IP Holdings, LLC

patents

5. 1 out of 1

Slap Pharmaceuticals LLC

patent

Years Active: 2002-2024

Loading Chart...

Areas of Expertise:

Pharmaceutical Chemistry

NK1 Antagonists

ERK Inhibitors

Multicyclic Compounds

Dihydropyrazoles

Spiro Compounds

Inflammatory Disorders

Preparation Processes

Selective Antagonists

Interleukin Receptor

Trifluoromethyl Phenyl

Carboxamide Inhibitors

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12054479 - Multicyclic compounds (2024-08-06),

2. 11261192 - Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones (2022-03-01),

3. 11124518 - L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs (2021-09-21),

4. 10196394 - Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor (2019-02-05),

5. 10000493 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2018-06-19),

6. 9969711 - [object Object] (2018-05-15),

7. 9688693 - [object Object] (2017-06-27),

8. 9469629 - [object Object] (2016-10-18),

9. 9260428 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2016-02-16),

10. 9169260 - Amidopyrazole inhibitors of interleukin receptor-associated kinases (2015-10-27),

11. 8796299 - NK1 antagonists (2014-08-05),

12. 8754216 - NK1 antagonists (2014-06-17),

13. 8716483 - Compounds that are ERK inhibitors (2014-05-06),

14. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 (2014-01-07),

15. 8552191 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2013-10-08),

Title: The Innovative Journey of Sunil Paliwal

Introduction: Sunil Paliwal, a talented inventor hailing from Monroe Township, NJ (US), has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents: Sunil Paliwal holds several patents in various technological domains, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his illustrious career, Sunil Paliwal has demonstrated a remarkable ability to transform ideas into tangible inventions that have the potential to revolutionize industries and improve people's lives.

Collaborations: Sunil Paliwal has collaborated with leading research institutions, universities, and companies to further his innovative projects, demonstrating his commitment to pushing the boundaries of technological advancements.

Conclusion: Sunil Paliwal's passion for innovation, coupled with his relentless pursuit of excellence, has established him as a prominent figure in the world of inventors, inspiring others to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.